US FDA authorizes Novavax’s updated COVID shot, shares rise
By Sriparna Roy and Michael Erman (Reuters) -The U.S. Food and Drug Administration said on Tuesday it authorized an updated version of Novavax’s COVID-19 vaccine for emergency use in individuals aged 12 years and older, and the company’s shares closed 8% higher. The Maryland-based company, whose COVID vaccine is its lone marketed product, has adopted …
US FDA authorizes Novavax’s updated COVID shot, shares rise Read More »









